Patents by Inventor Fiona KUO

Fiona KUO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • JAK1 pathway inhibitors for the treatment of vitiligo
    Patent number: 11957661
    Abstract: This disclosure relates to JAK1 pathway inhibitors and their use in treating vitiligo.
    Type: Grant
    Filed: December 8, 2021
    Date of Patent: April 16, 2024
    Assignee: Incyte Corporation
    Inventors: Paul Smith, Kurt Andrew Brown, Michael D. Howell, Fiona Kuo, James Lee, Leandro Luiz Dos Santos, Beth Rumberger
  • TOPICAL TREATMENT OF VITILIGO
    Publication number: 20230364095
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 16, 2021
    Publication date: November 16, 2023
    Applicant: INCYTE CORPORATION
    Inventors: Kathleen BUTLER, Jim LEE, Kang SUN, Fiona KUO, Michael HOWELL
  • TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR
    Publication number: 20230355628
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 8, 2022
    Publication date: November 9, 2023
    Inventors: Kathleen BUTLER, Jim LEE, Kang SUN, Fiona KUO, Michael HOWELL
  • TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR
    Publication number: 20230293431
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof based on results from long term clinical studies.
    Type: Application
    Filed: February 28, 2023
    Publication date: September 21, 2023
    Inventors: Kathleen BUTLER, Jim Lee, Kang SUN, Fiona KUO, Michael HOWELL
  • Topical treatment of vitiligo by a JAK inhibitor
    Patent number: 11602536
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: June 10, 2020
    Date of Patent: March 14, 2023
    Assignee: Incyte Corporation
    Inventors: Kathleen Butler, Jim Lee, Kang Sun, Fiona Kuo, Michael Howell
  • Topical treatment of vitiligo by a jak inhibitor
    Patent number: 11590138
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 8, 2022
    Date of Patent: February 28, 2023
    Assignee: Incyte Corporation
    Inventors: Kathleen Butler, Jim Lee, Kang Sun, Fiona Kuo, Michael Howell
  • TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR
    Publication number: 20220409622
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 8, 2022
    Publication date: December 29, 2022
    Inventors: Kathleen BUTLER, Jim LEE, Kang SUN, Fiona KUO, Michael HOWELL
  • JAK1 PATHWAY INHIBITORS FOR THE TREATMENT OF VITILIGO
    Publication number: 20220175731
    Abstract: This disclosure relates to JAK1 pathway inhibitors and their use in treating vitiligo.
    Type: Application
    Filed: December 8, 2021
    Publication date: June 9, 2022
    Inventors: Paul Smith, Kurt Andrew Brown, Michael D. Howell, Fiona Kuo, James Lee, Leandro Luiz Dos Santos, Beth Rumberger
  • TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR
    Publication number: 20210030672
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: September 16, 2020
    Publication date: February 4, 2021
    Inventors: Kathleen BUTLER, Jim LEE, Kang SUN, Fiona KUO, Michael HOWELL
  • TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR
    Publication number: 20200405627
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 10, 2020
    Publication date: December 31, 2020
    Inventors: Kathleen BUTLER, Jim LEE, Kang SUN, Fiona KUO, Michael HOWELL
  • TOPICAL TREATMENT OF VITILIGO BY A JAK INHIBITOR
    Publication number: 20200383986
    Abstract: The present disclosure relates to topical treatment of vitiligo using ruxolitinib, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 10, 2020
    Publication date: December 10, 2020
    Inventors: Kathleen BUTLER, Jim LEE, Kang SUN, Fiona KUO, Michael HOWELL